#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ornithine transcarbamoylase deficiency Indolent systemic mastocytosis Haemophilia A without inhibitors Congenital megacolon Cutaneous lupus erythematosus Anaplastic large cell lymphoma T- and null-cell types Cytokine release syndrome Netherton's syndrome Malignant glioma Conjunctivitis allergic Leiomyosarcoma Endometrial cancer recurrent Retinoblastoma Kearns-Sayre syndrome Atypical haemolytic uraemic syndrome More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Encephalitis autoimmune – Trials in Disease Systemic mastocytosis – Life with Disease Leukoencephalopathy – Basic Information Pemphigoid – Treatment Hepatoblastoma – Life with Disease Nephroblastoma – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Minoxidil 177LU-PSMA-I&T AB521 Amphotericine B, Liposome R-Azasetron Besilate Dinoprostone Serpina1(Human)-Aav8-1 Mk-2060 GOLD SODIUM THIOSULFATE Calcium Polystyrene Sulfonate Granisetron Minocycline PALAZESTRANT Phleum Pratense Pollen Extract Meldonium Ropivacaine Hydrochloride Cefepime Air, Medicinal Rosnilimab More therapies…

    Learn about Your Condition

    Right ventricular dysfunction Prostatitis Escherichia coli Seasonal allergy Encephalitis autoimmune Lumbosacral radiculopathy Gastrooesophageal cancer Cervix carcinoma Meniere's disease Takayasu's arteritis Ataxia telangiectasia Coronary artery bypass Skin disorder Behavioural addiction Haemolytic uraemic syndrome Hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France Spain

  • A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • RO7268489
    • Ocrelizumab
    France Germany Hungary Italy Poland Portugal +1

  • A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Ivonescimab
    • Bevacizumab
    • Fluorouracil
    Belgium Czechia France Germany Hungary Italy +2

  • Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Treprostinil Palmitil
    Austria Belgium Czechia Denmark France Germany +6

  • A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • HUMAN POLYCLONAL IMMUNOGLOBULIN G AGAINST THYMOCYTE
    • Sodium Chloride
    Austria Belgium Denmark Finland France Germany +5

  • Study Using Fluorescent Adalimumab and Risankizumab to See How These Drugs Work in Patients with Inflammatory Bowel Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Risankizumab
    • Adalimumab
    The Netherlands
Previous Page
1 … 88 89 90 91 92 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!